HB 1443 Illinois House · 104th Regular Session

HEALTH CARE AVAILABILITY

Summary
Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Prohibits the Board from creating an upper payment limit that is different from the Medicare Maximum Fair Price for the prescription drug product that has a Medicare Maximum Fair Price. Requires the Board to implement an upper payment limit that is the same as the Medicare Maximum Fair Price no sooner than the Medicare implementation date. Provides that Medicare Part C and D plans are not required to reimburse at the upper payment limit. Provides that the Attorney General may enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.
Bill status died 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 17, 2025 Last action Apr 17, 2026
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Engrossed · 6 edits
MODERATE
The bill was renamed from the 'Health Care Availability and Access Board Act' to the 'Prescription Drug Affordability Board Act.' The changes include updating the name of the board and its stakeholder council, adding a new definition for 'Health benefit plan,' and expanding the required expertise of board members to include the practice of pharmacy. These revisions clarify the bill's focus on drug affordability and ensure the board includes representatives with specific pharmacy expertise.
Scope change
The bill's scope remains focused on protecting residents from high prescription drug costs, but the terminology now explicitly emphasizes 'affordability' and the board's composition now requires expertise in pharmacy practice.
DEFINITION

The short title of the Act was changed from 'Health Care Availability and Access Board Act' to 'Prescription Drug Affordability Board Act' to better reflect the bill's primary goal.

The definition of the 'Board' was updated to match the new short title, changing 'Health Care Availability and Access Board' to 'Prescription Drug Affordability Board'.

The definition of the 'Council' was updated to match the new short title, changing 'Health Care Availability and Access Stakeholder Council' to 'Prescription Drug Affordability Stakeholder Council'.

A new definition for 'Health benefit plan' was added, referencing the existing Illinois Insurance Code.

The definition of a 'Generic drug' was slightly refined to explicitly state it is marketed under an 'abbreviated new drug application'.

REQUIREMENT

The requirements for board member expertise were expanded to include 'the practice of pharmacy' in addition to health care economics, pharmaceutical markets, and clinical medicine.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
86
Key actions
7
Committee
18
Amendments
5
Apr 17, 2026
Committee
House Floor Amendment No. 3 Rule 19(c) / Re-referred to Rules Committee
lower
Apr 17, 2026
Committee
House Floor Amendment No. 2 Rule 19(c) / Re-referred to Rules Committee
lower
Apr 17, 2026
Committee
House Floor Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
lower
Apr 17, 2026
Committee
Rule 19(a) / Re-referred to Rules Committee
lower
Apr 16, 2026
Lower · Passed
House Floor Amendment No. 4 Adopted
lower
Apr 16, 2026
Lower · Passed
House Floor Amendment No. 4 Recommends Be Adopted Health Care Availability & Accessibility Committee; 009-005-000
lower
Apr 16, 2026
Lower · Passed
House Floor Amendment No. 4 Rules Refers to Health Care Availability & Accessibility Committee
lower
Apr 15, 2026
Committee
House Floor Amendment No. 4 Referred to Rules Committee
lower
Apr 15, 2026
Introduced
House Floor Amendment No. 4 Filed with Clerk by Rep. Nabeela Syed
lower
Apr 15, 2026
Lower · Passed
House Floor Amendment No. 3 Rules Refers to Health Care Availability & Accessibility Committee
lower
Apr 15, 2026
Committee
House Floor Amendment No. 3 Referred to Rules Committee
lower
Apr 15, 2026
Introduced
House Floor Amendment No. 3 Filed with Clerk by Rep. Nabeela Syed
lower
Apr 14, 2026
Lower · Passed
House Floor Amendment No. 2 Rules Refers to Health Care Availability & Accessibility Committee
lower
Apr 14, 2026
Committee
House Floor Amendment No. 2 Referred to Rules Committee
lower
Apr 14, 2026
Introduced
House Floor Amendment No. 2 Filed with Clerk by Rep. Nabeela Syed
lower
Apr 8, 2026
Lower · Passed
House Floor Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee
lower
Apr 8, 2026
Committee
House Floor Amendment No. 1 Referred to Rules Committee
lower
Apr 8, 2026
Introduced
House Floor Amendment No. 1 Filed with Clerk by Rep. Nabeela Syed
lower
Mar 24, 2026
Lower · Passed
Do Pass / Short Debate Health Care Availability & Accessibility Committee; 008-004-000
lower
Mar 12, 2026
Committee
Assigned to Health Care Availability & Accessibility Committee
lower
Mar 21, 2025
Committee
Rule 19(a) / Re-referred to Rules Committee
lower
Feb 18, 2025
Committee
Assigned to Health Care Availability & Accessibility Committee
lower
Jan 28, 2025
Committee
Referred to Rules Committee
lower
1 primary · 29 co-sponsors

Sponsors